SEVEN-YEAR TRENDS IN THE CROATIAN PRIMARY PERCUTANEOUS CORONARY INTERVENTION NETWORK

Acta Clinica Croatica
|December 16, 2015
PubMed

Insights

Croatian heart attack treatment improved with percutaneous coronary intervention (PCI) despite sicker patients and new centers. While door-to-balloon times decreased, prehospital delays remain a concern for STEMI outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • The Croatian primary Percutaneous Coronary Intervention (pPCI) Network has treated ST-elevation myocardial infarction (STEMI) patients since 2005.
  • Assessing network performance over time is crucial for understanding treatment trends and outcomes.

Purpose of the Study:

  • To evaluate trends in STEMI treatment outcomes within the Croatian pPCI Network over three distinct time periods.
  • To analyze changes in patient risk profiles, treatment times, and major adverse cardiovascular events (MACE).

Main Methods:

  • Retrospective analysis of 5650 STEMI patients treated with pPCI across 11 centers between 2005 and 2011.
  • Comparison of patient demographics, clinical characteristics, door-to-balloon times, and MACE rates across three phases: 2005-2007, 2008-2009, and 2010-2011.
  • Multivariate log-linear analysis to assess the impact of risk profiles on treatment outcomes.

Main Results:

  • The number of STEMI patients treated annually with pPCI significantly increased over the study period.
  • Patient risk profiles worsened, indicated by increased age, anterior wall involvement, shock rates, and a higher percentage of transferred patients.
  • Door-to-balloon times decreased significantly, but symptom onset-to-door times increased. Final TIMI 3 flow, in-hospital, and six-month mortality rates showed no significant changes.
  • Angina pectoris and other MACE rates increased significantly over time, potentially due to changes in pPCI strategy and increased center availability.

Conclusions:

  • The Croatian pPCI Network demonstrated sustained high-quality STEMI treatment despite a worsening patient risk profile and network expansion.
  • Improvements in door-to-balloon times were achieved, but reducing prehospital delays is essential for further optimization.
  • Increased MACE rates may be linked to evolving treatment strategies and greater access to post-STEMI PCI procedures.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
554
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K